The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

Maternal RSV vaccination and nirsevimab were associated with a reduction in RSV hospitalization rates in infants aged 0 to 7 months during the 2024-2025 RSV season.

The nation’s infant mortality rate dropped last year after two years of hovering at a late-pandemic plateau. Some ...

RSV-NET data showed that RSV hospitalization rates among infants aged 0 to 7 months were an estimated 43% (95% confidence ...

Vermont has the second lowest state fatality rate in the US (147.3 per 100K; Hawaii 112.9/100K). Mississippi (464.7/100K) and ...

Maternal RSV vaccination and nirsevimab were associated with a reduction in hospitalization rates among infants aged 0 to 7 months.

In a letter sent Tuesday, Sen. Lisa Blunt Rochester (D-Del.) demanded that health secretary Robert Kennedy clarify whether ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

The delayed meeting of the CDC's main vaccines advisory committee has taken place, with new recommendations on respiratory syncytial virus (RSV) vaccines that do away with restrictions imposed ...

Agencies working under Robert F. Kennedy Jr. are changing the nation's decades-old system for approving vaccines. The shift ...

Highlights Walking pneumonia is a milder form of regular pneumonia. It can be contagious when caused by specific bacteria or ...

After the FDA asked for more clinical data this month, Moderna has decided to resubmit the BLA later this year.